Janus Henderson Investors US’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Janus Henderson Investors US's LLY Position: Q1 2017 in Review
Janus Henderson Investors US increased its Eli Lilly (LLY) stake by 2.8% in Q1 2017, buying an estimated $19M and bringing the position to 8,723,692 shares worth $734M. The position accounts for 0.6% of the portfolio, ranked #30.
Janus Henderson Investors US first reported a position in LLY in Q2 2013 and has held it in 16 quarters since. The position peaked at $901M in Q4 2015. 1,250 funds tracked by Wall St. Rank hold LLY as of Q1 2017.
- Janus Henderson Investors US held 8,723,692 shares of Eli Lilly worth $734M as of Q1 2017.
- Janus Henderson Investors US bought 237,619 Eli Lilly shares in Q1 2017, an estimated $19M.
- Eli Lilly made up 0.6% of Janus Henderson Investors US's portfolio in Q1 2017, its #30 holding.
- Janus Henderson Investors US first reported a position in Eli Lilly in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Eli Lilly position peaked at $901M in Q4 2015.
- 1,250 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.